Category: 3. Business

The Wegovy pill launched Monday, and the starting dose is now available at pharmacies around the country with higher doses arriving by the end of the week.

The Food and Drug Administration approved the pill for obesity on Dec. 22. It’s also approved to reduce the risk of heart attack and stroke in patients who are obese or overweight.

The pill follows the blockbuster success of Novo Nordisk’s Wegovy injection, which has been on the market since 2021 and became so popular that it was in short supply until February 2025.

The pill version of the drug helped patients lose about as much weight as the injection. In a study published in the New England Journal of Medicine, a 25 milligram Wegovy pill led to a 13.6% reduction in weight on average over 64 weeks. Patients taking a placebo in the study lost 2.2% of their weight. For patients who stayed on the treatment, reduced their calorie intake and exercised, Novo Nordisk estimates they would have a 16.6% reduction in their weight.

However, patients need to take the Wegovy pill on an empty stomach and wait a half hour before eating anything else for the medicine to be properly absorbed. The most common side effects with the Wegovy pill are similar to the injection and include nausea, diarrhea and vomiting.

When Novo Nordisk announced its drug-pricing deal with the Trump administration in November, it promised to make the obesity pill available for $149 a month to patients not using their health insurance. However, that’s only the starting dose for the direct-to-consumer price. The higher doses will be available for $299 a month.

The price that affects insurance coverage, called a list price, is the same as the Wegovy injection: $1,349 a month.

Insurance coverage for obesity drugs became more restrictive in 2025, according to an analysis from GoodRx, a website that helps patients find discounts on prescription drugs. But Novo Nordisk says patients with insurance coverage can get the Wegovy pill for as low as $25 a month.

Although the Wegovy pill is the first of its kind to win FDA approval, Novo Nordisk’s Type 2 diabetes pill, Rybelsus, is already on the market. It contains the same active ingredient, semaglutide, but the doses are different.

Eli Lilly, which makes the Zepbound injection, applied to the FDA in late 2025 for approval of its competing obesity pill. The agency gave the company a voucher for a priority review and a decision could come early this year.

NEW YORK – January 5, 2026 – The Goldman Sachs Group, Inc. (NYSE:GS) today announced that Hans Swildens, Justin Burden, and Roland Reynolds have joined Goldman Sachs as Partners in its Asset and Wealth Management business.  

The three will join the firm’s External Investing Group (XIG) within Goldman Sachs Asset Management as part of the closing of the Industry Ventures acquisition. In their roles, they will continue to focus on managing key parts of the Industry Ventures business, including investment processes, operations, and limited partner relationships. 

Hans Swildens founded Industry Ventures, and served as its CEO, managing the overall business. He brings decades of experience to the firm as an early pioneer of the modern secondary market for venture capital and early supporter of the development of a new class of venture capital partnerships focused on seed and early stage investing during the last decade.

Earlier in his career, Hans co-founded and acted as president of Microline Software. He also helped start Speedera Networks (acquired by Akamai) and provided board advisory services to Discovery Mining (acquired by Interwoven), nCircle Network Security (acquired by Tripwire), and StepUp Commerce (acquired by Intuit).

Hans earned an MBA from Columbia Business School and a BA with distinction from the University of California at Santa Barbara.

Justin Burden served as senior managing director at Industry Ventures. In this capacity, he has focused on originating, valuing, and managing secondary investment opportunities in later-stage, venture-backed companies and venture capital funds. He has also been actively involved in fundraising and maintaining limited partner relationships. Justin joined Industry Ventures in 2004.

Previously, Justin worked at GE Equity in San Francisco, the venture capital arm of the General Electric Company, where he sourced, structured, and managed investments in the technology, consumer, media, and telecom sectors. Prior to GE Equity, Justin worked at Wells Fargo’s high yield fund purchasing debt securities in buyout transactions.

Justin earned a bachelor’s degree from the University of California, Berkeley and an MSc from the London School of Economics.

Roland Reynolds served as senior managing director at Industry Ventures. In this role, he has focused on originating, valuing, and managing primary fund commitments, early secondary limited partnership investments, and direct company investments for the Industry Ventures Direct and Partnership Holdings team. He has also been actively involved in fundraising and maintaining limited partner relationships.

Previously, Roland was founder of Little Hawk Capital Management LLC, which was acquired by Industry Ventures. He also spent five years as Principal with Columbia Capital, a leading communications and information technology venture capital firm. Earlier in his career, Roland was an investment banker with JP Morgan & Co. in New York.

Roland graduated from Princeton University with high honors and earned his MBA from Harvard Business School.

###

About Goldman Sachs Asset Management

Goldman Sachs Asset Management is the primary investing area within Goldman Sachs, delivering investment and advisory services across public and private markets for the world’s leading institutions, financial advisors, and individuals. The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets. Goldman Sachs Asset Management is a leading investor across fixed income, liquidity, equity, alternatives, and multi-asset solutions. Goldman Sachs oversees approximately $3.5 trillion in assets under supervision as of September 30, 2025. Follow us on LinkedIn.

About Goldman Sachs Alternatives

Goldman Sachs Alternatives is one of the leading investors globally, with approximately $576 billion in assets as of September 30, 2025 and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs. The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.

 

Goldman Sachs Media Relations

Mary Athridge

+1 212 902 5400

mary.athridge@gs.com

Goldman Sachs Investor Relations

Jehan Ilahi

+1 212 902 0300

Jehan.ilahi@gs.com

Paris, January 5, 2026 – Meeting on January 5, 2026, the Board of Directors of Capgemini SE took due note of Ms. Megan Clarken‘s resignation as a director and decided to appoint by co-option[1] a new director, Ms. Lila Tretikov, following a proposal by the Ethics and Governance committee.

Ms. Lila Tretikov, a French and American national, is currently Head of AI Strategy, at New Enterprise Associates, Inc., a global venture capital firm. She will bring to the Board her technological skills and her expertise in Artificial Intelligence as well as business transformation through technology.

The Board considers Ms. Lila Tretikov to be independent pursuant to the criteria of the AFEP-MEDEF Code to which the Company refers.

Ms. Lila Tretikov’s nomination is effective from January 5, 2026.  This nomination is in line with the Board’s ambition to enrich the diversity of its profiles and deepen its industry expertise.

The Board of Directors warmly thanked Ms. Megan Clarken for her contribution to the work of the Board and the Strategy & CSR Committee on which she sat.

As of January 5,2026, the Board of Directors therefore comprises 15 directors, including two directors representing employees and one director representing employee shareholders. 83% of its members are independent[2], 40% have international profiles and 42% are women².

BIOGRAPHY

Ms. Lila Tretikov

Ms. Tretikov is a leading expert on Artificial Intelligence and innovation-driven business transformation. Since 2024, she has been Partner, and Head of AI Strategy, at New Enterprise Associates, Inc., a global venture capital firm based in Silicon Valley.

Ms. Tretikov studied computer science (specializing in AI) and visual art at the University of California, Berkeley.

Prior to joining New Enterprise Associates, Ms. Tretikov was employed by Microsoft Corporation since 2018. She notably held the position of Corporate Vice President & Deputy Chief Technology Officer from April 2020 to January 2024, driving large-scale AI transformation.

Previously, Ms. Tretikov served as Senior Vice President of Engie SA, a multinational energy company, and Chief Executive Officer and Vice Chairman of the Terrawatt Initiative, a non-profit corporation launched by Engie, Total, IBM, and other multinationals to accelerate decarbonization of global industries. She was previously Chief Executive Officer and Executive Director of The Wikimedia Foundation and Wikipedia Endowment, which support Wikipedia. Ms. Tretikov sits on the Board of Directors of UBS Group AG, Volvo Car Corporation, and Xylem Inc.

[1] Ms. Lila Tretikov will serve the remainder of Ms. Clarken’s mandate until 2027 at the AGM convened to approve the 2026 statutory accounts. Ms. Megan Clarken left her position on December 31, 2025.

[2] The Directors representing employees and employee shareholders are not taken into account in calculating this percentage, in accordance with the provisions of the AFEP-MEDEF Code and the French Commercial Code.

Editor’s note: The University of Delaware is diligently working to enhance infrastructure and support available to campus innovators. As part of this effort, the U.S. National Science Foundation’s Accelerating Research Translation program (NSF ART program) at UD is investing in capacity-building resources to boost the translation of UD research discoveries into novel technologies of benefit to Delawareans and the nation. UD is an inaugural member of the NSF ART program.

For thousands of years, our clothing has primarily been used for protective and aesthetic uses. University of Delaware inventor Sagar Doshi thinks apparel is capable of more. He wants to make our clothing smarter, so that we can get more information about how we move.

Why is this necessary? About 3 million Americans undergo physical therapy each year to recover from injuries such as a ligament tear, or after surgery, such as a knee replacement. 

Doshi, a research scientist at the Center for Composite Materials (CCM) and a research assistant professor of mechanical engineering, is developing next-generation wearable technologies with the ability to provide physical therapy clinicians and athletic trainers with useful data to make data-driven decisions about their patient’s or athlete’s recovery. 

The UD-developed nanomaterial-based sensors embedded in Doshi’s wearable technologies contain carbon nanocomposites, which are over 1,000 times smaller than a human hair and impart unique electrical properties when deposited on everyday fabrics like cotton, polyester or elastane. This allows the material to measure precise changes in human movement. Combined with the newest repair technologies, these novel sensors also have the potential to make our civil infrastructure safer, from bridges to pipelines. 

These are big aspirations for a technology that grew out of Doshi’s UD doctoral work. That early research led Doshi in directions he had dreamed about but wasn’t sure how to make happen … from inventor to patent holder to entrepreneur. He didn’t get there alone. He’s had significant help along the way.

As an Innovation Ambassador at UD, Doshi wants campus inventors to know how the UD innovation ecosystem has been there for him — and that this growing network is available to others, too.

Tell us about your invention.

Doshi: We are developing the next generation of wearable technology. The key problem that we are trying to address through this invention is providing improved techniques that clinicians, physical therapists and athletic trainers can use to measure progress or improvement for patients and athletes who are undergoing rehab after an injury. We are going beyond what Fitbit and smartwatches can do. The data our wearable technologies collect can help physical therapists, clinicians and athletic trainers to make informed and data-driven decisions for providing better care to patients and athletes so that they can safely recover faster.

Al Husn Hotel Muscat, Hilton Muscat Al Bandar, and DoubleTree by Hilton Muscat Al Waha begin welcoming guests

MUSCAT, Oman – Hilton (NYSE: HLT) has introduced three hotels at Barr Al Jissah, a landmark waterfront destination celebrated for its natural beauty.

Nestled between the cliffs of Al Jissah and the Gulf of Oman, the properties offer a blend of family-friendly options, vibrant event spaces, and elevated luxury experiences. Owned by The Zubair Corporation and located just 40 minutes from Muscat International Airport, the openings usher in a new chapter of world-class hospitality along Oman’s coastline.

Guy Hutchinson, president, Middle East & Africa, Hilton, said, “As Oman’s travel and tourism sector continues to thrive, we are proud to open these three hotels at Barr Al Jissah – the country’s iconic seaside destination. We look forward to contributing to its success through our portfolio of world-class brands and our global network. Together with The Zubair Corporation, we aim to strengthen Oman’s position as a leading tourism destination, supporting the nation’s Vision 2040 goal of attracting 11 million visitors annually and driving sustainable growth in the sector.”

Niels Bormans, group chief executive officer, The Zubair Corporation, said, “Today marks a milestone moment for Barr Al Jissah and for Oman’s hospitality sector as a whole. We are pleased to officially welcome Hilton as the new operator of Barr Al Jissah Resorts, confident that their global experience, operational excellence, and shared commitment to quality will further elevate the three hotels. This partnership reflects our belief in long-term value creation through world-class collaborations that support tourism growth and talent development, in line with the goals of Oman Vision 2040.”

The three hotels at Barr Al Jissah each deliver a distinct yet complementary experience.

Hilton Muscat Al Bandar is Barr Al Jissah’s lifestyle and business hub. With state-of-the-art indoor and outdoor event spaces, including a ballroom accommodating up to 850 guests, expansive outdoor event spaces and a dedicated amphitheater, Hilton Muscat Al Bandar is a premier venue for weddings, corporate events, and large-scale gatherings. At the heart of the 198 guest-room property is a lively poolside bar, La Jolla, alongside a selection of restaurants and lounges.

DoubleTree by Hilton Muscat Al Waha offers a relaxed, family-friendly experience rooted in comfort, beginning with the DoubleTree chocolate chip cookie welcome. The resort features 302 spacious guest rooms and suites, and its architecture reflects the charm of an Omani village, creating a sense of place that feels authentic and inviting. Perfect for family getaways, the resort boasts multiple pools and a waterslide along with access to shared facilities across Barr Al Jissah.

The three hotels share the extensive recreational, dining, and leisure amenities of the Barr Al Jissah complex, ensuring a seamless guest journey across the destination. Shared recreational facilities include multiple swimming pools, tennis courts, a lazy river, and over 500 meters of private beachfront. Guests can also enjoy water sports such as kayaking and diving, with a PADI-certified dive centre offering courses suitable for all experience levels. Wellness enthusiasts will appreciate the destination’s spa facilities, which include The Spa, offering treatments inspired by Omani Rose, and Luban Spa, known for its use of Frankincense.

The hotels are part of Hilton Honors, the award-winning guest loyalty programme for Hilton’s 25 world-class brands. Members who book directly have access to instant benefits, including a flexible payment slider that allows members to choose nearly any combination of Points and money to book a stay, an exclusive member discount, free standard Wi-Fi and the Hilton Honors mobile app. Book direct at hilton.com, through the Hilton Honors app or through other official Hilton channels for more perks and a price match guarantee. Hilton Honors members can redeem Points using the Points Explorer tool. 

For more information, or to make a reservation, travelers may visit hilton.com or call +968 2477 6262. For more information on Hilton, please visit stories.hilton.com/emea

Samsung Electronics Co., Ltd., a global leader in technology, today announced that Spatial Signage has been recognized by the Consumer Technology Association (CTA)® as part of the CES Innovation Awards ® 2026 program. The award marks Samsung’s first-ever recognition in the Enterprise Technology category, coinciding with the company’s commercial display debut at the show.

Each year, the world-renowned CES Innovation Awards honor outstanding design and engineering across a vast range of technology products. As the #1 leader in global digital signage for 16 years,¹ this recognition further reinforces Samsung’s commitment to providing best-in-class display signage and solutions that help captivate and convert shoppers into customers.

First introduced at IFA 2025, Spatial Signage is a glasses-free 3D display that delivers an immersive visual experience. Using Samsung’s breakthrough display technology, it delivers immersive realism by adding multidimensional depth to 2D visuals, creating more captivating shopping experiences with existing content. The display’s sleek 2.1-inch profile and slim 85-inch frame allow for seamless placement in design-conscious environments, from big box chains to luxury stores and even stadiums. With Samsung VXT built in, users can remotely deploy in-store content across devices, from vivid images of in-store merchandise to enticing promotional offers.

Spatial Signage will be on display during official show hours at the Samsung Exhibition Zone at The Wynn Las Vegas from January 5-7, 2026.

For more on Samsung Spatial Signage, visit Samsung.com.

• Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official
• FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer.

SANTA ANA, California, January 5, 2026 – FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, today announced the Company has officially changed its legal name from FUJIFILM Irvine Scientific, Inc., to FUJIFILM Biosciences Inc., effective January 1, 2026. The FUJIFILM Biosciences’ name builds upon the Company’s roots as a pioneer in the cell culture media industry that through a core focus on people, innovation, and quality now serves a much broader life science community and customers.

FUJIFILM Biosciences continues to be dedicated to its customers with a focus on empowering scientists and researchers at every stage of discovery, development, and commercialization. By offering a comprehensive portfolio of products and services in cell culture media, feeds, specialty chemicals and reagents, single-use technologies, and human-induced pluripotent stem cell capabilities, the Company supports and helps accelerate the development of life-changing treatments that can improve patient outcomes worldwide.

“All of us at FUJIFILM Biosciences take immense pride in being a people-focused company that empowers our colleagues to create an exceptional customer experience,” said Brandon Pence, president and chief operating officer, FUJIFILM Biosciences. “We utilize our 55-year legacy of deep industry knowledge to collaboratively develop innovative solutions and technologies that are supplied from our global network of manufacturing facilities. With this approach and our ongoing investments, we look ahead to a strong future with our employees, customers, and partners around the world.”

ENDS

For high-res images, please contact lily.jeffery@zymecommunications.com

Notes to Editors